article thumbnail

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog

Department of Health and Human Services (HHS) recently published a White Paper on Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States —with input from several HHS stakeholders, including FDA, CMS, and the Administration for Strategic Preparedness and Response. By Kalie E.

article thumbnail

Four Ways Trump’s ‘One Big Beautiful Bill’ Would Undermine Access to Obamacare

Physician's Weekly

Also, as soon as the end of this year, a special enrollment period the Biden administration created would be done away with. This affects people in states that use the federal marketplace as well as the 19 states and the District of Columbia that run their own, most of which offer open enrollment into at least mid-January.